Meyka AI API is live for developers.Start building.
Advertisement
Iterum Therapeutics plc

Iterum Therapeutics plc (ITRMF) Stock Overview

Explore Iterum Therapeutics plc’s financial performance, market position, analyst ratings, and future outlook.

ITRMF●PNK
HealthcareBiotechnology
$0.04
$0.005(12.25%)
U.S. Market opens in 10h 58m
Advertisement

Iterum Therapeutics plc (ITRMF)

Meyka AI Score

Z

Key Financials

Market Cap1.9M
P/E Ratio-0.06
EPS (TTM)$-0.72
ROE6.02%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

ITRMF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Iterum Therapeutics plc (ITRMF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 43.97, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.06 and a market capitalization of 1.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-12.25%
5-Day Change
-29.80%
1-Month Change
-33.14%
3-Month Change
-79.49%
6-Month Change
-92.20%
Year-to-Date (YTD) Change
-89.52%
1-Year Change
-96.48%
3-Year Change
-96.84%
5-Year Change
-99.89%
All-Time (Max) Change
-99.98%

Contact Information

https://www.iterumtx.com
353 1 903 8354
3 Dublin Landings, Dublin, NaN, D01 C4E0

Company Facts

9 Employees
IPO DateMay 25, 2018
CountryIE
Actively Trading

Frequently Asked Questions